Vitamin E, a modifier of platelet function: Rationale and use in cardiovascular and cerebrovascular disease

Nutrition Reviews

Volumn 57, Issue 10, 1999, Pages 306-309

  Steiner, Manfred ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTITHROMBOCYTIC AGENT; PROTEIN KINASE C;

ANTIOXIDANT ACTIVITY; BLEEDING DISORDER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DRUG MECHANISM; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; REVIEW; RISK BENEFIT ANALYSIS; THROMBOCYTE ADHESION; THROMBOCYTE FUNCTION; TRANSIENT ISCHEMIC ATTACK;

EID: 0032704131     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1999.tb06903.x     Document Type: Review

References (31)

1. Hussain QZ, Newcomb TF. Thrombin stimulation of platelet oxygen consumption rate. J Appl Physiol 1964;19:297-300
2. Steiner M, Anastasi J. Vitamin E, an inhibitor of the platelet release reaction. J Clin Invest 1976;57: 732-7
3. Higashi O, Kikuchi Y. Effects of vitamin E on the aggregation and the lipid peroxidation of platelets exposed to hydrogen peroxide. Tohoku J Exp Med 1974;112:271-8
4. Machlin LJ, Filipski R, Willis AL, Kuhn DC. Influence of vitamin E on platelet aggregation and thrombocythemia in the rat. Proc Soc Exp Biol Med 1975;149:275-7
5. Fong JS. Alpha-tocopherol, its inhibition on human platelet aggregation. Experientia 1976;32:639-41
6. Mower R, Steiner M. Biochemical interaction of arachidonic acid and vitamin E in human platelets. Prostaglandins Leukotrienes Medicine 1983;10: 389-403
7. Steiner M. Inhibition of platelet aggregation by alpha-tocopherol. In: De Duve C, Hayaishi Elsevier O, eds. Tocopherol, oxygen and biomembranes. Amsterdam: North Holland Biomedical Press, 1978;143-63
8. Steiner M. Effect of α-tocopherol administration on platelet function in man. Thromb Haemost 1983; 49:73-7
9. Davies MJ, Thomas T. The pathological basis and microanatomy of occlusive thrombus formation in human coronary arteries. Philos Trans R Soc Lond B Biol Sci 1981;294:225-9
10. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363-73
11. Jandak J, Steiner M, Richardson PD. α-Tocopherol, an effective inhibitor of platelet adhesion. Blood 1989;73:141-9
12. Cox AC, Rao GH, Gerrard JM, White JG. The influence of vitamin E quinone on platelet structure, function and biochemistry. Blood 1980;55:907-14
13. Mower R, Steiner M. Synthetic by-products of tocopherol oxidation as inhibitors of platelet function. Prostaglandins 1982;24:137-47
14. Werner MH, Hannun YA. Delayed accumulation of diacylglycerol in platelets as a mechanism for regulation of onset of aggregation and secretion. Blood 1991;78:435-44
15. Geanacopoulos M, Turner J, Bowling KE, et al. The role of protein kinase C in the initial events of platelet activation by thrombin assessed with a selective inhibitor. Thromb Res 1993;69:113-24
16. Chatelain E, Boscoboinik DO, Bartoli GM, et al. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim Biophys Acta 1993;1176:83-9
17. Tabilio A, Rosa J-P, Testa U, et al. Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL). EMBO J 1984;3:453-9
18. Steiner M, Li W, Ciaramella JM, et al. Dl-alpha-tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro- and megakaryoblastic leukemia cells. J Cell Physiol 1997;172:351-60
19. Baldassare JJ, Henderson PA, Burns D, et al. Translocation of protein kinase C isozymes in thrombinstimulated human platelets: correlation with 1,2-diacylglycerol levels. J Biol Chem 1992;267: 15585-90
20. Steiner M, Glantz M, Lekos A. Vitamin E plus aspirin compared with aspirin alone in patients with treatment ischemic attacks. Am J Clin Nutr 1995;62(suppl):1381-4
21. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6
22. Davies MJ, Thomas AC. Thrombosis and acute coronary artery lesion in sudden cardiac ischemic death. New Engl J Med 1984;310:1137-40
23. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6
24. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9
25. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35
26. Liede KE, Haukka JK, Saxen LM, Heinonen OP. Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid. Ann Med 1998;30:542-6
27. Dowd P, Zheng ZB. On the mechanism of the anticlotting action of vitamin E quinone. Proc Natl Acad Sci U S A 1995;92:8171-5
28. Corrigan JJ. The effect of vitamin E on warfarin-induced vitamin K deficiency. Ann N Y Acad Sci 1982;393:361-8
29. Hillman RW. Tocopherol excess in man: creatinuria associated with prolonged ingestion. Am J Clin Nutr 1957;5:597-600
30. March BE, Wong E, Seier L. Hypervitaminosis E in the chick. J Nutr 1973;103:371-7
31. Takahashi O, Ichikawa H, Sasaki M. Hemorrhagic toxicity of d-α-tocopherol in the rat. Toxicology 1990;63:157-65